BAYER AG- ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BAYER AG- ADR with three other
companies in this sector in the United States:
sales of $50.36 billion
of which 60%
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 44%
was Operating Segment-Global Established Pha).
BAYER AG- ADR reported sales of $51.09 billion
December of 2015.
decrease of 8.4%
versus 2014, when the company's sales were $55.77 billion.
Contributing to the drop in overall sales was the 52.3% decline
in Reconciliations, from $9.24 million to $4.41 million.
There were also decreases in sales in
Pharmaceuticals and Biological Products (down 4.7% to $15.16 billion)
Materialscience (down 14.1% to $13.22 billion)
Cropscience (down 8.8% to $11.43 billion)
Consumer Care (down 3.8% to $10.07 billion)
All Other Segments (down 17.6% to $1.21 billion)